241 related articles for article (PubMed ID: 25389338)
41. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
42. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
[TBL] [Abstract][Full Text] [Related]
43. CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry.
Ting YS; Smith SABC; Brown DA; Dodds AJ; Fay KC; Ma DDF; Milliken S; Moore JJ; Sewell WA
Int J Lab Hematol; 2018 Oct; 40(5):533-539. PubMed ID: 29806244
[TBL] [Abstract][Full Text] [Related]
44. Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia.
Huh YO; Keating MJ; Saffer HL; Jilani I; Lerner S; Albitar M
Am J Clin Pathol; 2001 Sep; 116(3):437-43. PubMed ID: 11554173
[TBL] [Abstract][Full Text] [Related]
45. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
Poongodi R; Varma N; Naseem S; Parveen B; Varma S
Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
[TBL] [Abstract][Full Text] [Related]
46. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
Li W; Fang P; Fu G; Liang H; Peng M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
[TBL] [Abstract][Full Text] [Related]
47. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
Saksena A; Yin CC; Xu J; Li J; Zhou J; Wang SA; Lin P; Tang G; Wang L; Wang M; Miranda RN; Medeiros LJ; Li S
Hum Pathol; 2019 Jul; 89():71-80. PubMed ID: 31054894
[TBL] [Abstract][Full Text] [Related]
48. Flow cytometric expression of CD71, CD81, CD44 and CD39 in B cell lymphoma.
Espasa A; Tapia G; Vergara S; Raya M; Juncà J; Sorigue M
Scand J Clin Lab Invest; 2021 Sep; 81(5):413-417. PubMed ID: 34057378
[TBL] [Abstract][Full Text] [Related]
49. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
[TBL] [Abstract][Full Text] [Related]
50. Quantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation.
Menendez P; Vargas A; Bueno C; Barrena S; Almeida J; De Santiago M; López A; Roa S; San Miguel JF; Orfao A
Leukemia; 2004 Mar; 18(3):491-8. PubMed ID: 14724650
[TBL] [Abstract][Full Text] [Related]
51. B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma involving bone marrow with an interfollicular pattern.
Kim YS; Ford RJ; Faber JA; Bell RH; Elenitoba-Johnson KS; Medeiros LJ
Am J Clin Pathol; 2000 Jul; 114(1):41-6. PubMed ID: 10884798
[TBL] [Abstract][Full Text] [Related]
52. Lymphoma of the ocular adnexa: A study of 353 cases.
Ferry JA; Fung CY; Zukerberg L; Lucarelli MJ; Hasserjian RP; Preffer FI; Harris NL
Am J Surg Pathol; 2007 Feb; 31(2):170-84. PubMed ID: 17255761
[TBL] [Abstract][Full Text] [Related]
53. [Correlation of results of flow cytometry and morphologic findings in the diagnosis of malignant B-cell lymphoma].
Mand'áková P; Campr V; Kodet R
Cas Lek Cesk; 2003; 142(11):651-5. PubMed ID: 14689823
[TBL] [Abstract][Full Text] [Related]
54. Aberrant expression of CD8 in B-cell non-Hodgkin lymphoma: a multicenter study of 951 bone marrow samples with lymphomatous infiltration.
Carulli G; Stacchini A; Marini A; Ciriello MM; Zucca A; Cannizzo E; Aliberti S; Demurtas A; Novero D; Calcagno L; Callegari T; Petrini M
Am J Clin Pathol; 2009 Aug; 132(2):186-90; quiz 306. PubMed ID: 19605812
[TBL] [Abstract][Full Text] [Related]
55. Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings.
Sovani V; Harvey C; Haynes AP; McMillan AK; Clark DM; O'Connor SR
J Clin Pathol; 2014 May; 67(5):389-95. PubMed ID: 24327662
[TBL] [Abstract][Full Text] [Related]
56. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
Babusíková O; Zelezníková T; Mlcáková A; Kusenda J; Stevulová L
Neoplasma; 2005; 52(6):502-9. PubMed ID: 16284697
[TBL] [Abstract][Full Text] [Related]
57. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T
Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579
[TBL] [Abstract][Full Text] [Related]
58. Demonstration of a germinal center immunophenotype in lymphomas by immunocytochemistry and flow cytometry.
Jack A; Barrans S; Blythe D; Rawstron A
Methods Mol Med; 2005; 115():65-91. PubMed ID: 15998963
[TBL] [Abstract][Full Text] [Related]
59. Use of CD137 ligand expression in the detection of small B-cell lymphomas involving the bone marrow.
Zhao S; Xing Y; Natkunam Y
Hum Pathol; 2014 May; 45(5):1024-30. PubMed ID: 24746207
[TBL] [Abstract][Full Text] [Related]
60. Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry.
Muzzafar T; Medeiros LJ; Wang SA; Brahmandam A; Thomas DA; Jorgensen JL
Am J Clin Pathol; 2009 Nov; 132(5):692-8. PubMed ID: 19846809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
